Skip to main content

Table 2 Treatment outcomes for participants finishing follow-up as part of therapeutic efficacy monitoring in Angola, 2015

From: Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015

  n (%)
Benguela Zaire Lunda Sul
ASAQa ALa ALa DPb DPb ASAQa
n = 73 n = 85 n = 93 n = 84 n = 76 n = 56
Treatment failure 7 (10) 9 (11) 23 (25) 15 (18) 0 0
 Early treatment failure 0 1 (1) 3 (3) 0 0 0
 Late treatment failure 7 (10) 8 (9) 20 (22) 15 (18) 0 0
 Recrudescence 0 1 (1) 8 (9) 1 (1) 0 0
  Day 7 0 0 0 0 0 0
  Day 14 0 0 2 (2) 0 0 0
  Day 21 0 0 6 (6) 0 0 0
  Day 28 0 1 (1) 0 1 (1) 0 0
  Day 35 0 0
  Day 42 0 0
 Reinfection 7 (10) 7 (8) 12 (13) 14 (17) 0 0
  Day 7 0 0 0 0 0 0
  Day 14 0 2 (2) 1 (1) 0 0 0
  Day 21 1 (1) 1 (1) 6 (6) 0 0 0
  Day 28 6 (8) 1 (1) 5 (5) 3 (4) 0 0
  Day 35 5 (6) 0
  Day 42 6 (7) 0
Adequate clinical and parasitological response 66 (90) 76 (89) 70 (75) 69 (82) 76 (100) 56 (100)
  1. ASAQ artesunate–amodiaquine, AL artemether–lumefantrine, DP dihydroartemisinin–piperaquine
  2. a28-day follow-up
  3. b42-day follow-up